CEP290 and hepatocellular carcinoma: CEP290 was highly expressed in HCC specimens from the TCGA-LIHC cohort (n=419) (Figure 3A), and the ROC curve showed that upregulation of CEP290 showed good diagnostic performance for HCC (Figure 3B; AUC=0.783; p<0.0001).